• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎患者嗅觉和味觉功能障碍的发生率及预测效度

Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection.

作者信息

Pérula de Torres Luis Ángel, González-Lama Jesús, Jiménez García Celia, Sánchez Montero Rosa, Rider Garrido Faustino, Ortega López Yolanda, Pajares Conde Diego, Ramírez Baena Miguel, Párraga Martínez Ignacio, Romero-Rodríguez Esperanza

机构信息

Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía, Universidad de Córdoba, Córdoba, Spain.

Unidad Docente Multiprofesional de Atención Familiar y Comunitaria de Córdoba, Córdoba, Spain.

出版信息

Med Clin (Engl Ed). 2021 Jun 25;156(12):595-601. doi: 10.1016/j.medcle.2020.12.024. Epub 2021 May 24.

DOI:10.1016/j.medcle.2020.12.024
PMID:34056110
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8141902/
Abstract

BACKGROUND AND OBJECTIVE

Olfactory and taste dysfunction (OD, TD) have been considered symptoms of SARS-CoV-2 infection. However, its presence in certain populations, especially those with mild clinical symptoms, has not been clarified. The objective was to estimate the frequency of OD and TD, and its predictive validity in patients detected in Primary Care.

PATIENTS AND METHODS

A cross-sectional study was carried out in the Spanish National Health System. An epidemiological survey was administered to patients who were requested the PCR test for SARS-CoV-2. Odds ratio (OR) were estimated to measure the magnitude of the association between OD and TD and the existence of SARS-CoV-2 infection. The sensitivity, specificity, and positive and negative predictive values (PPV, NPV) of these symptoms in SARS-CoV-2 infection were calculated.

RESULTS

Of 1038 patients screened, 20.1% had SARS-CoV-2 infection. OD and DG were present in 64.4% (95% CI 56.0-72.1) and 56.2% (95% CI 47.9-64.2) of the subjects with infection, respectively. The OR for OD was 12.2 (95% CI 8.26-18.06) and for TD was 7.95 (95% CI 5.48-11.53). TD presented a sensitivity of 41.1% (95% CI 34.4-46.1), a specificity of 91.9% (95% CI 89.8-93.7), a PPV of 56.2% (95% CI48.0-64.2) and a NPV of 86.1% (95% CI 83.6-88.3), while the OD showed a sensitivity of 45.0% (95% CI 37.6-51.5), a specificity of 93.7% (95% CI 91.8-95.0), a PPV of 64.4% (95% CI 56.0-72.1) and a NPV of 87.1% (95% CI 84.7-89.2).

CONCLUSIONS

More than half of the subjects with SARS-CoV-2 infection have OD or TD. The presence of OD or TD could be of diagnostic utility due to its ability to predict infection in more than half of the cases.

摘要

背景与目的

嗅觉和味觉功能障碍(OD,TD)被认为是新型冠状病毒感染的症状。然而,其在某些人群中的存在情况,尤其是那些临床症状较轻的人群,尚未明确。目的是评估初级保健中检测到的患者中OD和TD的发生率及其预测有效性。

患者与方法

在西班牙国家卫生系统中进行了一项横断面研究。对接受新型冠状病毒PCR检测的患者进行了一项流行病学调查。估计比值比(OR)以衡量OD和TD与新型冠状病毒感染存在之间关联的强度。计算了这些症状在新型冠状病毒感染中的敏感性、特异性以及阳性和阴性预测值(PPV,NPV)。

结果

在1038名筛查患者中,20.1%感染了新型冠状病毒。感染患者中分别有64.4%(95%可信区间56.0 - 72.1)和56.2%(95%可信区间47.9 - 64.2)出现OD和TD。OD的OR为12.2(95%可信区间8.26 - 18.06),TD的OR为7.95(95%可信区间5.48 - 11.53)。TD的敏感性为41.1%(95%可信区间34.4 - 46.1),特异性为91.9%(95%可信区间89.8 - 93.7),PPV为56.2%(95%可信区间48.0 - 64.2),NPV为86.1%(95%可信区间83.6 - 88.3),而OD的敏感性为45.0%(95%可信区间37.6 - 51.5),特异性为93.7%(95%可信区间91.8 - 95.0),PPV为64.4%(95%可信区间56.0 - 72.1),NPV为87.1%(95%可信区间84.7 - 89.2)。

结论

超过一半的新型冠状病毒感染患者存在OD或TD。OD或TD的存在因其能够在一半以上的病例中预测感染,可能具有诊断价值。

相似文献

1
Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection.新型冠状病毒肺炎患者嗅觉和味觉功能障碍的发生率及预测效度
Med Clin (Engl Ed). 2021 Jun 25;156(12):595-601. doi: 10.1016/j.medcle.2020.12.024. Epub 2021 May 24.
2
Frequency and predictive validity of olfactory and taste dysfunction in patients with SARS-CoV-2 infection.新型冠状病毒感染患者嗅觉和味觉障碍的频率及预测价值。
Med Clin (Barc). 2021 Jun 25;156(12):595-601. doi: 10.1016/j.medcli.2020.12.015. Epub 2021 Jan 28.
3
Olfactory and taste dysfunctions caused by COVID-19: a nationwide study.新冠病毒引发的嗅觉和味觉功能障碍:一项全国性研究。
Rhinology. 2023 Dec 1;61(6):552-560. doi: 10.4193/Rhin23.034.
4
Smell and taste alterations in COVID-19: a cross-sectional analysis of different cohorts.COVID-19 患者的嗅觉和味觉改变:不同队列的横断面分析。
Int Forum Allergy Rhinol. 2020 Aug;10(8):955-962. doi: 10.1002/alr.22610. Epub 2020 Jun 25.
5
Long-term prevalence of taste and olfactory dysfunction in COVID-19 patients: A cross-sectional study.新冠病毒感染者味觉和嗅觉功能障碍的长期流行情况:一项横断面研究。
Oral Dis. 2022 Nov;28 Suppl 2:2516-2521. doi: 10.1111/odi.14231. Epub 2022 Jun 5.
6
Is Olfactory Testing a Useful Diagnostic Tool to Identify SARS-CoV-2 Infections Early? A Cross-Sectional and Longitudinal Analysis.嗅觉测试是早期识别新型冠状病毒感染的有用诊断工具吗?一项横断面和纵向分析。
J Clin Med. 2023 Apr 27;12(9):3162. doi: 10.3390/jcm12093162.
7
Clinical Presentation of the SARS-CoV-2 Virus Infection and Predictive Validity of the PCR Test in Primary Health Care Worker Patients of the Spanish National Health System.西班牙国家卫生系统基层医护人员患者中SARS-CoV-2病毒感染的临床表现及PCR检测的预测有效性
J Clin Med. 2022 Jan 4;11(1):243. doi: 10.3390/jcm11010243.
8
Olfactory Dysfunction and Sinonasal Symptomatology in COVID-19: Prevalence, Severity, Timing, and Associated Characteristics.新冠病毒感染患者的嗅觉功能障碍和鼻-鼻窦症状:流行率、严重程度、出现时间和相关特征。
Otolaryngol Head Neck Surg. 2020 Jul;163(1):114-120. doi: 10.1177/0194599820929185. Epub 2020 May 19.
9
Olfactory and taste dysfunctions in COVID-19.新型冠状病毒肺炎患者的嗅觉和味觉障碍。
Curr Opin Allergy Clin Immunol. 2021 Jun 1;21(3):229-244. doi: 10.1097/ACI.0000000000000735.
10
Symptoms and symptom clusters associated with SARS-CoV-2 infection in community-based populations: Results from a statewide epidemiological study.社区人群中与新型冠状病毒感染相关的症状和症状群:一项全州范围流行病学研究的结果
medRxiv. 2020 Oct 22:2020.10.11.20210922. doi: 10.1101/2020.10.11.20210922.

引用本文的文献

1
Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis.味觉丧失是 COVID-19 的一个独特症状:系统评价和荟萃分析。
Chem Senses. 2023 Jan 1;48. doi: 10.1093/chemse/bjad043.
2
Clinical and Epidemiological Profiles of Primary Healthcare Professionals with COVID-19 Infection and Long COVID: An Observational Study.感染新冠病毒及出现新冠后症状的基层医疗保健专业人员的临床和流行病学特征:一项观察性研究。
Healthcare (Basel). 2023 Jun 7;11(12):1677. doi: 10.3390/healthcare11121677.
3
Long COVID Symptomatology and Associated Factors in Primary Care Patients: The EPICOVID-AP21 Study.基层医疗患者的长期新冠症状及相关因素:EPICOVID-AP21研究
Healthcare (Basel). 2023 Jan 11;11(2):218. doi: 10.3390/healthcare11020218.
4
Neuro-Immune Interactions in Severe COVID-19 Infection.重症新型冠状病毒肺炎感染中的神经免疫相互作用
Pathogens. 2022 Oct 29;11(11):1256. doi: 10.3390/pathogens11111256.
5
Exploring the Clinical Utility of Gustatory Dysfunction (GD) as a Triage Symptom Prior to Reverse Transcription Polymerase Chain Reaction (RT-PCR) in the Diagnosis of COVID-19: A Meta-Analysis and Systematic Review.探索味觉功能障碍(GD)作为新冠病毒疾病(COVID-19)诊断中逆转录聚合酶链反应(RT-PCR)之前的分诊症状的临床效用:一项荟萃分析和系统评价。
Life (Basel). 2021 Nov 29;11(12):1315. doi: 10.3390/life11121315.
6
Clinical Features of Early Stage COVID-19 in a Primary Care Setting.基层医疗环境中早期新冠病毒病的临床特征
Front Med (Lausanne). 2021 Nov 23;8:764884. doi: 10.3389/fmed.2021.764884. eCollection 2021.
7
Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis.味觉丧失作为新冠病毒病的一种独特症状:一项系统综述和荟萃分析。
medRxiv. 2021 Oct 9:2021.10.09.21264771. doi: 10.1101/2021.10.09.21264771.

本文引用的文献

1
Systematic Review and Meta-analysis of Smell and Taste Disorders in COVID-19.新型冠状病毒肺炎嗅觉和味觉障碍的系统评价与荟萃分析
OTO Open. 2020 Sep 11;4(3):2473974X20957975. doi: 10.1177/2473974X20957975. eCollection 2020 Jul-Sep.
2
Sudden olfactory loss as an early marker of COVID-19: a nationwide Italian survey.嗅觉丧失突然成为 COVID-19 的早期标志物:一项意大利全国范围的调查。
Eur Arch Otorhinolaryngol. 2021 Jan;278(1):247-255. doi: 10.1007/s00405-020-06252-9. Epub 2020 Aug 4.
3
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.西班牙 2020 年人群血清流行病学研究(ENE-COVID):全国范围内基于人群的血清流行病学研究。
Lancet. 2020 Aug 22;396(10250):535-544. doi: 10.1016/S0140-6736(20)31483-5. Epub 2020 Jul 6.
4
[The alteration of smell and taste in COVID-19 patients. A diagnostic resource in primary care].[新冠病毒感染患者的嗅觉和味觉改变。基层医疗中的一种诊断资源]
Aten Primaria. 2020 Oct;52(8):592-593. doi: 10.1016/j.aprim.2020.05.005. Epub 2020 May 27.
5
Focusing on health-care providers' experiences in the COVID-19 crisis.关注医疗保健提供者在新冠疫情危机中的经历。
Lancet Glob Health. 2020 Jun;8(6):e740-e741. doi: 10.1016/S2214-109X(20)30214-X. Epub 2020 Apr 29.
6
A minimal common outcome measure set for COVID-19 clinical research.用于 COVID-19 临床研究的最小通用结局指标集。
Lancet Infect Dis. 2020 Aug;20(8):e192-e197. doi: 10.1016/S1473-3099(20)30483-7. Epub 2020 Jun 12.
7
Predictive Value of Sudden Olfactory Loss in the Diagnosis of COVID-19.突发嗅觉丧失在COVID-19诊断中的预测价值
ORL J Otorhinolaryngol Relat Spec. 2020;82(4):175-180. doi: 10.1159/000509143. Epub 2020 Jun 11.
8
Quantifying additional COVID-19 symptoms will save lives.量化新冠病毒疾病的其他症状将拯救生命。
Lancet. 2020 Jun 20;395(10241):e107-e108. doi: 10.1016/S0140-6736(20)31281-2. Epub 2020 Jun 4.
9
Relationship between odor intensity estimates and COVID-19 prevalence prediction in a Swedish population.瑞典人群中气味强度估计与新冠病毒病患病率预测之间的关系
Chem Senses. 2020 May 22. doi: 10.1093/chemse/bjaa034.
10
Real-time tracking of self-reported symptoms to predict potential COVID-19.实时跟踪自我报告的症状以预测潜在的 COVID-19。
Nat Med. 2020 Jul;26(7):1037-1040. doi: 10.1038/s41591-020-0916-2. Epub 2020 May 11.